about
Anticalins: the lipocalin family as a novel protein scaffold for the development of next-generation immunotherapies.Direct crosstalk between mast cell-TNF and TNFR1-expressing endothelia mediates local tissue inflammation.PDE8 regulates rapid Teff cell adhesion and proliferation independent of ICER.Vitiligo puzzle: the pieces fall in place.Modulation of postoperative cognitive decline via blockade of inflammatory cytokines outside the brainVaccines against myasthenia gravis.Production of IL-16 correlates with CD4+ Th1 inflammation and phosphorylation of axonal cytoskeleton in multiple sclerosis lesions.Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study.Design of effective immunotherapy for human autoimmunity.Cholecalciferol plus calcium suppresses abnormal PBMC reactivity in patients with multiple sclerosis.From cellular receptors to transduction-transcription pathways for cytokines: at which level should the inhibition be targeted in inflammation?Heat-shock protein 60 as a tool for novel therapeutic strategies that target the induction of regulatory T cells in human arthritis.The histamine H4 receptor in autoimmune disease.Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review.The P66Shc/mitochondrial permeability transition pore pathway determines neurodegeneration.Mitomycin C-treated dendritic cells inactivate autoreactive T cells: toward the development of a tolerogenic vaccine in autoimmune diseases.Autoimmunity in atherosclerosis: a protective response losing control?Potential therapeutic role of statins in neurological disorders.Differential Expression and Function of PDE8 and PDE4 in Effector T cells: Implications for PDE8 as a Drug Target in Inflammation.In vivo delivery of a microRNA-regulated transgene induces antigen-specific regulatory T cells and promotes immunologic tolerance.Chromogranin A is a T cell antigen in human type 1 diabetes.Autoantibodies in neuromuscular autoimmune disorders.Monoclonal antibody therapy in multiple sclerosis: Paradigm shifts and emerging challenges.Induction of immune tolerance in the treatment of rheumatoid arthritis.Endometriosis-associated infertility: double intrauterine insemination improves fecundity in patients positive for antiendometrial antibodies.Current therapeutic leads for the treatment of autoimmune diseases: stem cell transplantation and inhibition of post-translational modifications of autoantigens.T cells use two directionally distinct pathways for cytokine secretion.Multiple sclerosis: An old drug plays a new trick.Discontinuation of infliximab in rheumatoid arthritis patients in clinical remission.Synthesis of glycopeptides from type II collagen-incorporating galactosylated hydroxylysine mimetics and their use in studying the fine specificity of arthritogenic T cells.Protective Effects on Central Nervous System by Acidic Polysaccharide of Panax ginseng in Relapse-Remitting Experimental Autoimmune Encephalomyelitis-Induced SJL/J Mice.Association of pelvic endometriosis with alopecia universalis, autoimmune thyroiditis and multiple sclerosis.
P2860
Q30157932-9284BDC8-C1E6-4ED1-B8E6-EA3A66841500Q30489747-1F4B42AD-45D2-4F4C-BEC1-E464CF6B9E5FQ30987183-845388CD-292D-4FFA-B6C2-17FAE8B8B40CQ33344607-96FB341E-9015-485D-AC72-0E183118601AQ34376036-842F85E9-0B83-41B2-A4AF-4BA1ADF12694Q34433908-0A13861C-E114-4BD6-A75A-CD74C8BD013DQ34715993-4919E977-1870-4553-B3E0-368DD19FAD2AQ35953233-7DCDF468-48E5-4458-8DAD-0AED9AA0767BQ36148416-36A8B93C-7232-4EC0-AFC9-DD8ED7921ED4Q36158139-F055C66A-9095-434A-B0AA-C534DE386DD0Q36269632-CC8873EE-B3AE-47AE-9C71-86CF888D2125Q36480993-E0C676E9-9573-4FDD-9AAD-997CD9EE39DCQ36623087-567FF091-DE41-435B-9154-B89173F580AEQ36640081-B5EE4E3F-BAC0-429E-B43D-CB57B631DB79Q36701020-EB0ABF12-0C07-4016-890B-300F5EBE2CDCQ36898560-05B92112-4D91-4CBB-8CC1-FEAD30CA6DB5Q36976323-2244FEAE-8CF9-44B2-8458-5BF95DC8865EQ37138017-9FF97ACF-8BD0-4F5A-8FFA-B8D9A4D88B90Q37154822-E2125AAC-6644-4C15-B9E8-246570CD216CQ37195453-CB76CC3C-4CF3-4877-927D-4E49E4119600Q37472002-7AC53E38-7D02-4FC2-9435-5C6A89A0E7BDQ37716863-882248FB-BDFB-4D84-BA29-C66BF218C79BQ37754738-2264EA47-C923-4C98-9C8C-994F21BB4769Q37814815-11D4B8A6-E76E-4A5C-B6CE-81BCA14C1D5FQ37862081-DE11061B-F3C9-42AB-B1F1-01750220C6EAQ44962524-A73F2C17-D693-4835-A3C4-786714739135Q45263742-D83CD335-522C-4392-AE78-BA3EFE9B1F8AQ45948164-271CECD0-BB63-47DB-BA6C-CBF7476F01A4Q46406182-A0421DD2-913A-4FAD-A59A-838171248A70Q46554870-F3CB10B5-2358-4C1C-8920-17E6A8825CE9Q46664569-089C9075-89C5-4513-94D5-1D07CE6DB006Q51507880-CD35E3B3-E7ED-4009-B1E3-BA8BDBC0337AQ51810923-64250774-E590-416A-83D4-DF0564F8E5F2
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Immune therapy for autoimmune diseases.
@ast
Immune therapy for autoimmune diseases.
@en
type
label
Immune therapy for autoimmune diseases.
@ast
Immune therapy for autoimmune diseases.
@en
prefLabel
Immune therapy for autoimmune diseases.
@ast
Immune therapy for autoimmune diseases.
@en
P356
P1433
P1476
Immune therapy for autoimmune diseases.
@en
P2093
Lawrence Steinman
P304
P356
10.1126/SCIENCE.1099896
P407
P577
2004-07-01T00:00:00Z